NLTX logo

Neoleukin Therapeutics, Inc. Common Stock


NLTX: Neoleukin Therapeutics Inc operates as a biopharmaceutical company. The firm generates immunotherapies using de novo protein design technology. It uses computational methods to design proteins that demonstrate specific pharmaceutical properties that provide potentially superior therapeutic benefits over native proteins to treat serious diseases, including cancer, inflammatory, and autoimmune disorders. Its product line comprises NL-201, which is a combined IL-2 and IL-15 agonist designed to eliminate alpha receptor binding.


Show NLTX Financials

Consumer Interest
SEC Filings

Recent trades of NLTX by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by NLTX's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of NLTX in WallStreetBets Daily Discussion


Recent insights relating to NLTX

CNBC Recommendations

Recent picks made for NLTX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in NLTX

Corporate Flights

Flights by private jets registered to NLTX